1. Effects of alpha-fetoprotein on the occurrence and progression of hepatocellular carcinoma

   • Yifei Zheng
   • Mingyue Zhu
   • Mengsen Li

   Review – Cancer Research 28 July 2020 Pages: 2439 - 2446

   

2. Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer

   • Yu Zeng
   • Nanhong Li
   • Jian Huang

   Original Article – Cancer Research 05 July 2020 Pages: 2447 - 2460

   

3. Aberrant DNA methylation results in altered gene expression in non-alcoholic steatohepatitis-related hepatocellular carcinomas

   • Ying Tian
   • Eri Arai
   • Yae Kanai

   Original Article – Cancer Research Open access 19 July 2020 Pages: 2461 - 2477

   

4. A randomized, double-blind, placebo controlled, phase II study to evaluate the efficacy of ginseng in reducing fatigue in patients treated for head and neck cancer

   • Mauro Guglielmo
   • Patricia Di Pede
   • Paolo Bossi

   Original Article – Cancer Research 02 July 2020 Pages: 2479 - 2487

   

5. Oral cancer awareness campaign in Northern Germany: first positive trends in incidence and tumour stages

   • Katrin Hertrampf
   • Ron Pritzkuleit
   • Annika Waldmann

   Original Article – Cancer Research Open access 02 July 2020 Pages: 2489 - 2496

   

6. Ex vivo culture of head and neck cancer explants in cell sheet for testing chemotherapeutic sensitivity

   • Jaewang Lee
   • Ji Hyeon You
   • Jong-Lyel Roh

   Original Article – Cancer Research 03 July 2020 Pages: 2497 - 2507

   

7. Hypoxia-induced downregulation of B-cell translocation gene 3 confers resistance to radiation therapy of colorectal cancer

   • Dening Ma
   • Xinyi Gao
   • Zongtao Chai

   Original Article – Cancer Research 03 July 2020 Pages: 2509 - 2517

   

8. A novel metastatic promoter CEMIP and its downstream molecular targets and signaling pathway of cellular migration and invasion in SCLC cells based on proteome analysis

   • Li Li
   • Yingxing Pan
   • Jie Yang

   Original Article – Cancer Research 09 July 2020 Pages: 2519 - 2534

   

9. Personalizing vulvar cancer workflow in COVID-19 era: a proposal from Vul.Can MDT

   • Giorgia Garganese
   • Luca Tagliaferri
   • Gemelli Vul.Can MDT

   Original Article – Cancer Research 12 July 2020 Pages: 2535 - 2545

   

10. The prognostic value of leucine-rich repeat-containing G-protein (Lgr5) and its impact on clinicopathological features of colorectal cancer

    • Arkadiusz Gzil
    • Izabela Zarębska
    • Łukasz Szylberg

    Original Article – Cancer Research Open access 15 July 2020 Pages: 2547 - 2557

    

11. Potential of platinum-resensitization by Wnt signaling modulators as treatment approach for epithelial ovarian cancer

    • Till Kaltofen
    • Valentina Preinfalk
    • Fabian Trillsch

    Original Article – Cancer Research Open access 17 July 2020 Pages: 2559 - 2574

    

12. Systematic review and network meta-analyses of third-line treatments for metastatic colorectal cancer

    • Thomas Walter
    • Neil S. Hawkins
    • Paul J. Ross

    Review – Clinical Oncology Open access 27 July 2020 Pages: 2575 - 2587

    

13. Combined microscope and endoscopy total resection of primary pineal malignant melanoma: case report and literature review

    • Jibo Zhang
    • Zhongwei Xiong
    • Jincao Chen

    Review – Clinical Oncology 22 July 2020 Pages: 2589 - 2594

    

14. Primary tumor standardized uptake value (SUVmax) measured on ¹⁸F-FDG PET/CT and mixed NSCLC components predict survival in surgical-resected combined small-cell lung cancer

    • Zhenzhen Hui
    • Feng Wei
    • Xiubao Ren

    Original Article – Clinical Oncology Open access 03 June 2020 Pages: 2595 - 2605

    

15. PD-L1 and IDO1 expression and tumor-infiltrating lymphocytes in osteosarcoma patients: comparative study of primary and metastatic lesions

    • Yu Toda
    • Kenichi Kohashi
    • Yoshinao Oda

    Original Article – Clinical Oncology 09 May 2020 Pages: 2607 - 2620

    

16. Correlations between circulating tumor cell phenotyping and 18F-fluorodeoxyglucose positron emission tomography uptake in non-small cell lung cancer

    • Jiarong Bian
    • Ke Yan
    • Xingxiang Xu

    Original Article – Clinical Oncology 13 July 2020 Pages: 2621 - 2630

    

17. Low rectal cancer treatment strategies: a cohort study assessing watch and wait

    • João Cortez Pinto
    • António Dias Pereira
    • Isadora Rosa

    Original Article – Clinical Oncology 20 May 2020 Pages: 2631 - 2638

    

18. Expression of PD-L1, PD-L2, and IDO1 on tumor cells and density of CD8-positive tumor-infiltrating lymphocytes in early-stage lung adenocarcinoma according to histological subtype

    • Kazuki Takada
    • Gouji Toyokawa
    • Masaki Mori

    Original Article – Clinical Oncology 14 May 2020 Pages: 2639 - 2650

    

19. Camrelizumab in advanced or metastatic solid tumour patients with DNA mismatch repair deficient or microsatellite instability high: an open-label prospective pivotal trial

    • Jingde Chen
    • Ming Quan
    • Yong Gao

    Original Article – Clinical Oncology 04 July 2020 Pages: 2651 - 2657

    

20. Polypharmacy as a prognostic factor in older patients with advanced non-small-cell lung cancer treated with anti-PD-1/PD-L1 antibody-based immunotherapy

    • Taiki Hakozaki
    • Yukio Hosomi
    • Yusuke Okuma

    Original Article – Clinical Oncology 27 May 2020 Pages: 2659 - 2668

    

21. Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study

    • Chenwei Wang
    • Yadi Liao
    • Yunfei Yuan

    Original Article – Clinical Oncology 25 May 2020 Pages: 2669 - 2680

    

22. Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109)

    • A. Kurreck
    • M. Geissler
    • D. P. Modest

    Original Article – Clinical Oncology Open access 24 May 2020 Pages: 2681 - 2691

    

23. The effect of proton pump inhibitors on survival outcomes in advanced hepatocellular carcinoma treated with sorafenib

    • Warit Ruanglertboon
    • Michael J. Sorich
    • Ashley M. Hopkins

    Original Article – Clinical Oncology 24 May 2020 Pages: 2693 - 2697

    

24. Role of pleural and peritoneal metastasis in immune checkpoint inhibitors efficacy patients with non-small cell lung cancer: real-world data from a large cohort in France

    • Anne Aarnink
    • Jean David Fumet
    • Francois Ghiringhelli

    Original Article – Clinical Oncology 30 May 2020 Pages: 2699 - 2707

    

25. Preoperative biopsies as predictor for the necessity of inguinal lymph node surgery in squamous cell carcinoma of the vulva-a retrospective tertiary center analysis

    • Caroline Pahmeyer
    • Fabinshy Thangarajah
    • Bernd Morgenstern

    Original Article – Clinical Oncology Open access 07 June 2020 Pages: 2709 - 2712

    

26. Oncology services in corona times: a flash interview among German cancer patients and their physicians

    • Jens Büntzel
    • Michael Klein
    • Jutta Hübner

    Letter to the Editor 15 May 2020 Pages: 2713 - 2715

    

27. Appropriate arrangement of cancer treatment after COVID-19 epidemic peaks in China

    • Hongnan Mo
    • Binliang Liu
    • Fei Ma

    Letter to the Editor 30 May 2020 Pages: 2717 - 2718

28. Correction to: Afatinib is active in osteosarcoma cell lines

    • Marlid Cruz-Ramos
    • Yessica Zamudio-Cuevas
    • Flavio Solca

    Correction 19 August 2020 Pages: 2719 - 2719